Allergan (NYSE: AGN) commented on Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX) release of its second quarter 2014 earnings results.Following Valeant’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE